810 related articles for article (PubMed ID: 17916770)
21. Inhibition of factor XIa as a new approach to anticoagulation.
Schumacher WA; Luettgen JM; Quan ML; Seiffert DA
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):388-92. PubMed ID: 20139363
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
23. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.
Revenko AS; Gao D; Crosby JR; Bhattacharjee G; Zhao C; May C; Gailani D; Monia BP; MacLeod AR
Blood; 2011 Nov; 118(19):5302-11. PubMed ID: 21821705
[TBL] [Abstract][Full Text] [Related]
24. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
[TBL] [Abstract][Full Text] [Related]
25. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
[TBL] [Abstract][Full Text] [Related]
26. Congenital factor XI deficiency: an update.
Duga S; Salomon O
Semin Thromb Hemost; 2013 Sep; 39(6):621-31. PubMed ID: 23929304
[TBL] [Abstract][Full Text] [Related]
27. Effect of heparin on the activation of factor XI by fibrin-bound thrombin.
von dem Borne PA; Meijers JC; Bouma BN
Thromb Haemost; 1996 Sep; 76(3):347-53. PubMed ID: 8883269
[TBL] [Abstract][Full Text] [Related]
28. Coagulation factor XI as a novel target for antithrombotic treatment.
Löwenberg EC; Meijers JC; Monia BP; Levi M
J Thromb Haemost; 2010 Nov; 8(11):2349-57. PubMed ID: 20727068
[TBL] [Abstract][Full Text] [Related]
29. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
[TBL] [Abstract][Full Text] [Related]
30. Activation of factor XI in plasma is dependent on factor XII.
Brunnée T; La Porta C; Reddigari SR; Salerno VM; Kaplan AP; Silverberg M
Blood; 1993 Feb; 81(3):580-6. PubMed ID: 8427954
[TBL] [Abstract][Full Text] [Related]
31. Advances and dilemmas in factor XI.
Gailani D
Curr Opin Hematol; 1994 Sep; 1(5):347-53. PubMed ID: 9371304
[TBL] [Abstract][Full Text] [Related]
32. Recent advances in haemostasis and thrombosis.
Vine AK
Retina; 2009 Jan; 29(1):1-7. PubMed ID: 19050668
[TBL] [Abstract][Full Text] [Related]
33. The intrinsic pathway of coagulation: a target for treating thromboembolic disease?
Gailani D; Renné T
J Thromb Haemost; 2007 Jun; 5(6):1106-12. PubMed ID: 17388803
[TBL] [Abstract][Full Text] [Related]
34. The hemostatic role of factor XI.
Puy C; Rigg RA; McCarty OJ
Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
[TBL] [Abstract][Full Text] [Related]
35. Factor Xa inhibitors: today and beyond.
Walenga JM; Jeske WP; Hoppensteadt D; Fareed J
Curr Opin Investig Drugs; 2003 Mar; 4(3):272-81. PubMed ID: 12735228
[TBL] [Abstract][Full Text] [Related]
36. 2017 Scientific Sessions Sol Sherry Distinguished Lecture in Thrombosis: Factor XI as a Target for New Anticoagulants.
Weitz JI; Fredenburgh JC
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):304-310. PubMed ID: 29269514
[TBL] [Abstract][Full Text] [Related]
37. Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.
Walsh PN; Griffin JH
Blood; 1981 Jan; 57(1):106-18. PubMed ID: 7004531
[No Abstract] [Full Text] [Related]
38. [The contact factors of hemostasis: examination of molecular evolution and new therapeutic perspectives].
Ponczek MB
Postepy Biochem; 2010; 56(1):67-74. PubMed ID: 20499683
[TBL] [Abstract][Full Text] [Related]
39. Factor XI deficiency in animal models.
Renné T; Oschatz C; Seifert S; Müller F; Antovic J; Karlman M; Benz PM
J Thromb Haemost; 2009 Jul; 7 Suppl 1():79-83. PubMed ID: 19630774
[TBL] [Abstract][Full Text] [Related]
40. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
